METTL3 and metabolic dysfunction-associated steatotic liver disease: In conclusion, our study proves that the methyltransferase, METTL3, can regulate m6A methylation of the CYP2B6 gene, antagonize insulin sensitivity through the insulin signaling pathway, and ultimately lead to the occurrence of IR in NAFLD.